Neutral
Catheter Precision Announces Brief 10-Q Filing Delay
Catheter Precision (VTAK) has announced a brief delay in its Form 10-Q filing for Q1 2026, which is attributed to the complex accounting required for ...
Neutral
Catheter Precision (VTAK) has announced a brief delay in its Form 10-Q filing for Q1 2026, which is attributed to the complex accounting required for ...
Bullish
Catheter Precision (NYSE:VTAK) reported a 200% year-over-year revenue increase in Q1 2026, reaching $432,000, largely driven by its medical device bus...
Catheter Precision (NYSE: VTAK) filed an amendment to its annual report, detailing extensive related-party transactions and director independence. The...